European Society of Cardiology: Dual Antiplatelet Therapy is Not More Effective Than Aspirin Alone After Coronary Artery Bypass Grafting
September 01, 2025
September 01, 2025
SOPHIA ANTIPOLIS, France, Sept. 1 -- The European Society of Cardiology issued the following news release:
* * *
Dual antiplatelet therapy is not more effective than aspirin alone after coronary artery bypass grafting
* ESC Guidelines recommend dual antiplatelet therapy (DAPT) for patients with acute coronary syndrome (ACS) who undergo coronary artery bypass grafting (CABG), although evidence from large, randomised trials is lacking.
* The TAC . . .
* * *
Dual antiplatelet therapy is not more effective than aspirin alone after coronary artery bypass grafting
* ESC Guidelines recommend dual antiplatelet therapy (DAPT) for patients with acute coronary syndrome (ACS) who undergo coronary artery bypass grafting (CABG), although evidence from large, randomised trials is lacking.
* The TAC . . .